These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34660835)

  • 41. Letermovir Rescue Therapy in Kidney Transplant Recipients with Refractory/Resistant CMV Disease.
    von Hoerschelmann E; Münch J; Gao L; Lücht C; Naik MG; Schmidt D; Pitzinger P; Michel D; Avaniadi P; Schrezenmeier E; Choi M; Halleck F; Budde K
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
    Marfori JE; Exner MM; Marousek GI; Chou S; Drew WL
    J Clin Virol; 2007 Feb; 38(2):120-5. PubMed ID: 17157554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy.
    Mendez JC; Sia IG; Tau KR; Espy MJ; Smith TF; Chou S; Paya CV
    Transplantation; 1999 Mar; 67(5):755-7. PubMed ID: 10096535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
    Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
    Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
    Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis.
    Boivin G; Goyette N; Gilbert C; Covington E
    J Med Virol; 2005 Nov; 77(3):425-9. PubMed ID: 16173018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.
    Bowen EF; Cherrington JM; Lamy PD; Griffiths PD; Johnson MA; Emery VC
    J Med Virol; 1999 Aug; 58(4):402-7. PubMed ID: 10421408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of a UL97 gene mutation conferring ganciclovir resistance in human cytomegalovirus: prevalence of the D605E polymorphism in Korean immunocompromised patients.
    Sung H; An D; Lee SO; Choi SH; Kim SH; Chi HS; Kim MN
    Ann Clin Lab Sci; 2012; 42(4):429-34. PubMed ID: 23090742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in the UL97 ORF of ganciclovir-resistant clinical cytomegalovirus isolates differentially affect GCV phosphorylation as determined in a recombinant vaccinia virus system.
    Baldanti F; Michel D; Simoncini L; Heuschmid M; Zimmermann A; Minisini R; Schaarschmidt P; Schmid T; Gerna G; Mertens T
    Antiviral Res; 2002 Apr; 54(1):59-67. PubMed ID: 11888658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.
    López-Aladid R; Guiu A; Mosquera MM; López-Medrano F; Cofán F; Linares L; Torre-Cisneros J; Vidal E; Moreno A; Aguado JM; Cordero E; Martin-Gandul C; Carratalá J; Sabé N; Niubó J; Cervera C; Capón A; Cervilla A; Santos M; Bodro M; Muñoz P; Fariñas MC; Antón A; Aranzamendi M; Montejo M; Pérez-Romero P; Len O; Marcos MÁ
    PLoS One; 2019; 14(7):e0219701. PubMed ID: 31318908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of Ganciclovir-Resistant Cytomegalovirus Infection Caused by the UL97 Gene Mutation in Codons 460 and 520 in Pediatric Patients: A Case Series.
    Boonsathorn S; Pasomsub E; Techasaensiri C; Apiwattanakul N
    Open Forum Infect Dis; 2019 Nov; 6(11):ofz480. PubMed ID: 32528998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.
    Boivin G; Goyette N; Gilbert C; Roberts N; Macey K; Paya C; Pescovitz MD; Humar A; Dominguez E; Washburn K; Blumberg E; Alexander B; Freeman R; Heaton N; Covington E
    J Infect Dis; 2004 May; 189(9):1615-8. PubMed ID: 15116297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients.
    Benzi F; Vanni I; Cassina G; Ugolotti E; Di Marco E; Cirillo C; Cristina E; Morreale G; Melioli G; Malnati M; Biassoni R
    J Clin Virol; 2012 May; 54(1):48-55. PubMed ID: 22300656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.
    Choi KY; Sharon B; Balfour HH; Belani K; Pozos TC; Schleiss MR
    J Clin Virol; 2013 Aug; 57(4):356-60. PubMed ID: 23688863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paradoxical rising cytomegalovirus antigenemia during preemptive ganciclovir therapy in hematopoietic stem cell transplant recipients: incidence, risk factors, and clinical outcomes.
    Park SY; Lee SO; Choi SH; Kim YS; Woo JH; Sung H; Kim MN; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
    J Clin Microbiol; 2011 Dec; 49(12):4179-84. PubMed ID: 22031700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.
    Mousavi-Jazi M; Hökeberg I; Schloss L; Zweygberg-Wirgart B; Grillner L; Linde A; Brytting M
    Transpl Infect Dis; 2001 Dec; 3(4):195-202. PubMed ID: 11844151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.
    Hantz S; Garnier-Geoffroy F; Mazeron MC; Garrigue I; Merville P; Mengelle C; Rostaing L; Saint Marcoux F; Essig M; Rerolle JP; Cotin S; Germi R; Pillet S; Lebranchu Y; Turlure P; Alain S;
    J Antimicrob Chemother; 2010 Dec; 65(12):2628-40. PubMed ID: 20961907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K; Kanda Y; Kako S; Asano-Mori Y; Watanabe T; Motokura T; Chiba S; Shiraki K; Kurokawa M
    J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.
    Cintra-Cabrera M; Suárez-Benjumea A; Bernal-Blanco G; González-Roncero FM; Toapanta-Gaibor NG; Súñer-Poblet M; Pérez-Valdivia MÁ; Fernández-Cuenca F; Gentil-Govantes MÁ; Rocha-Castilla JL
    Transplant Proc; 2018 Mar; 50(2):575-577. PubMed ID: 29579856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.